Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT03250923
CelAgace™ OraRinse Solution for Treatment of Candidiasis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2024
Completion: May 31, 2025